They bind to scavenger receptors and CD91, P2X purinoceptor 7 (P2RX7), and Toll-like receptor 2/4 (TLR2/4) on immature DCs respectively, facilitating the attraction and maturation of DCs capable of priming or reactivating tumor-specific T cells [24]. The gene discussed is LRP1; the disease is neoplasm.